Sangamo Therapeutics, Inc. (LON:0R1D)
London · Delayed Price · Currency is GBP · Price in USD 0.5045
+0.0045 (0.90%)
Dec 9, 2025, 7:10 PM BST
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of 127.2 million as of December 10, 2025. Its market cap has decreased by -60.49% in one year.
Market Cap
127.20M
Enterprise Value
124.05M
Revenue
24.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has increased from 58.46M to 127.20M, an increase of 117.60%. That is a compound annual growth rate of 3.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 127.42M | -25.04% |
| Dec 31, 2024 | 169.99M | 124.73% |
| Dec 29, 2023 | 75.64M | -82.29% |
| Dec 30, 2022 | 427.08M | -47.07% |
| Dec 31, 2021 | 806.88M | -50.09% |
| Dec 31, 2020 | 1.62B | 120.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.47B |
| Haleon | 32.12B |
| Smith & Nephew | 10.72B |
| Convatec Group | 4.47B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.83B |
| Genus | 1.73B |